Commonwealth Equity Services »

Neurosense Therapeutics shares owned by Commonwealth Equity Services

Quarter-by-quarter ownership of Neurosense Therapeutics (NRSN) shares owned by Commonwealth Equity Services from 13F filings

Historical chart of Commonwealth Equity Services investment in Neurosense Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Neurosense Therapeutics held by Commonwealth Equity Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurosense Therapeutics by Commonwealth Equity Services

Quarter filed Position value Share count Share price at filing
2025-09-30 $26k 21k 1.23
2025-06-30 $40k 21k 1.90
2025-03-31 $16k 17k 0.93
2024-12-31 $20k 16k 1.23
2024-09-30 $16k 13k 1.27

More positions owned by Commonwealth Equity Services

Apple (AAPL)
NVIDIA Corporation (NVDA)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Rus 1000 Grw Etf (IWF)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Growth Etf (VUG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Vanguard Index Fds Value Etf (VTV)
Vanguard Specialized Funds Div App Etf (VIG)

View all positions for Commonwealth Equity Services

Top funds holding Neurosense Therapeutics

Squarepoint Ops
Morgan Stanley
Meitav Dash Investments
Two Sigma Investments
Commonwealth Equity Services
Geode Capital Management
UBS Group
SBI Securities
Jones Financial Companies, L.L
CWM

View all funds holding Neurosense Therapeutics